Health Blueprint

Back to Longevity News

News summary

Leeds AI spinout adsilico raises £10M to test medical devices on virtual patients

Source: Tech.eu • Published: 26 Oct 2026, 08:30

Summarized by Masters of Longevity from Tech.eu.

University of Leeds spinout raised £10 million to expand AI virtual-patient simulations.

Leeds AI spinout adsilico raises £10M to test medical devices on virtual patients
Key Takeaways
  • Adsilico is creating virtual hearts and vessels from anonymised scans.
  • Their platform is using AI and physics simulations to test devices.
  • Evidence of human efficacy is not established in clinical trials.
Read the full article at Tech.eu ↗

Continue exploring

Recommended MoL Picks

MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.